200 GLP-1 Deaths, Chrissy Metz & a Stunning Harvard Study

<p>Https://www.otplinks.com</p><p>Based on the transcript flow, here’s a clean YouTube description with chapter timestamps. The transcript itself doesn’t include timecodes, so these are estimated from speaking pace and topic position. </p><p>A GLP-1 Death_ Chrissy Metz &amp; a Stunning Harvard Study.txt</p><p>More than 200 deaths in the UK have now been reported in association with GLP-1 medications, including the heartbreaking death of a 19-year-old woman taking tirzepatide.</p><p>But the headline does NOT tell the whole story.</p><p>Today, we unpack what those 216 reports actually mean, what investigators found in the death of Josephine Nassar, and why adverse-event reports are very different from proving a medication caused a death.</p><p>Plus, This Is Us star Chrissy Metz reveals she is using a GLP-1 to treat obesity, and I think what she did deserves a lot more respect than she’s getting.</p><p>Then we dig into a stunning new Harvard working paper examining what happened to women’s employment and relationship outcomes after starting GLP-1 treatment, and Starbucks becomes the latest major employer to pull GLP-1 coverage for obesity.</p><p>This is a BIG episode.</p><p>⏱️ CHAPTERS</p><p>00:00 The GLP-1 headlines you need to know<br>01:40 VoaFit / MyLevel<br>03:30 200+ GLP-1 deaths reported in the UK<br>04:25 The tragic death of 19-year-old Josephine Nassar<br>09:40 The hidden heart condition found after her death<br>12:30 Did tirzepatide contribute to her death?<br>15:35 What the UK’s 216 GLP-1 death reports actually mean<br>19:15 Pancreatitis and how regulators identify real safety signals<br>22:35 Chrissy Metz reveals she’s taking a GLP-1<br>24:35 Why Chrissy Metz’s decision to tell the truth was incredibly brave<br>27:05 Harvard’s stunning “Obesity Penalty” study<br>30:30 Starbucks drops GLP-1 coverage for obesity<br>33:10 What happens when employers stop paying for these drugs?<br>34:15 Final thoughts and your call to action</p><p>If you’ve lost significant weight, I want to hear from you: Did people start treating you differently?</p><p>And if your employer stopped covering your GLP-1, would you consider changing jobs to keep access to treatment?</p><p>👇 Drop your experience in the comments.</p><p>🔗 Keep up with everything On The Pen:<br><a href="http://linktr.ee/manonthemounjaro"><u>linktr.ee/manonthemounjaro</u></a></p><p>On The Pen brings you the stories and information that empower you to have better conversations with your doctor.</p><p>Subscribe and join us live every Monday, Wednesday and Friday at 11 AM Central / 12 PM Eastern.</p><p>#GLP1 #Mounjaro #Zepbound #Ozempic #Wegovy #Tirzepatide #WeightLoss #Obesity #ChrissyMetz</p><p>If you give me the actual final runtime of the uploaded video, I can tighten those timestamps much closer to the real chapter breaks.</p><p><br></p><p><br></p>